Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesPayablesPrepaid AssetsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Short term Debt (2023 - 2026)

Cannabis Bioscience International Holdings' Short term Debt history spans 4 years, with the latest figure at $14592.0 for Q1 2026.

  • On a quarterly basis, Short term Debt fell 80.07% to $14592.0 in Q1 2026 year-over-year; TTM through Feb 2026 was $14592.0, a 80.07% decrease, with the full-year FY2025 number at $14592.0, changed N/A from a year prior.
  • Short term Debt hit $14592.0 in Q1 2026 for Cannabis Bioscience International Holdings, roughly flat from $14592.0 in the prior quarter.
  • Over the last five years, Short term Debt for CBIH hit a ceiling of $73228.0 in Q1 2025 and a floor of $7054.0 in Q1 2024.
  • Historically, Short term Debt has averaged $19152.8 across 4 years, with a median of $14592.0 in 2023.
  • Biggest five-year swings in Short term Debt: skyrocketed 938.11% in 2025 and later plummeted 80.07% in 2026.
  • Tracing CBIH's Short term Debt over 4 years: stood at $12079.0 in 2023, then rose by 20.8% to $14592.0 in 2024, then changed by 0.0% to $14592.0 in 2025, then changed by 0.0% to $14592.0 in 2026.
  • Business Quant data shows Short term Debt for CBIH at $14592.0 in Q1 2026, $14592.0 in Q4 2025, and $14592.0 in Q2 2025.